mitoxantrone has been researched along with Bowel Diseases, Inflammatory in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vehreschild, MJ | 1 |
| Meissner, AM | 1 |
| Cornely, OA | 1 |
| Maschmeyer, G | 1 |
| Neumann, S | 1 |
| von Lilienfeld-Toal, M | 1 |
| Karthaus, M | 1 |
| Wattad, M | 1 |
| Staib, P | 1 |
| Hellmich, M | 1 |
| Christ, H | 1 |
| Vehreschild, JJ | 1 |
1 trial available for mitoxantrone and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Incidence; Inflam | 2011 |